On August 15, 2013, a federal jury in West Virginia returned a verdict in favor of a woman who suffered permanent injuries after she was implanted with defective transvaginal mesh. The 45-year-old woman underwent implantation of Avaulta transvaginal mesh manufactured by C.R. Bard, Inc. due to pelvic organ prolapse, a common ailment affecting many women. Following the mesh implantation, the plaintiff had numerous complications and was forced to undergo several surgical procedures to repair the damage caused by the defective mesh. At trial, it was revealed that C.R. Bard, Inc. executives knew that the Avaulta transvaginal mesh should not be implanted in humans, but nevertheless continued to market and sell the product. The jury found C.R. Bard, Inc. liable and awarded the plaintiff $250,000 in compensatory damages and $1,750,000 in punitive damages, a sign of the extent to which the jury found C.R. Bard, Inc. to be negligent and/or reckless in selling a product it knew was not fit for use in humans.

SUGARMAN principals Marianne LeBlanc and David McCormack continue to represent clients who have been implanted with defective or recalled transvaginal mesh products. If you believe you may be suffering from adverse medical complications as a result of a defective or recalled transvaginal mesh product, fill out a Contact Form, call Marianne LeBlanc or David McCormack at 617-542-1000 or e-mail Marianne LeBlanc or David McCormack.